Gepubliceerd in:
01-09-2016 | Erratum
Erratum to: The internal and external responsiveness of Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Short Form-12 Health Survey version 2 (SF-12 v2) in patients with prostate cancer
Gepubliceerd in: Quality of Life Research | Uitgave 9/2016
Log in om toegang te krijgenExcerpt
In the original publication of the article, the values in the row with row head (FACT-P total score**) of Table 1 have been moved to the next line inadvertently. However, the correct table is as follows (Table 1):
Table 1
Baseline characteristics of prostate cancer patients
|
Baseline (N = 291)
|
Follow-up (N = 168)
|
Attrition (N = 123)
|
||||
|---|---|---|---|---|---|---|
|
N
|
%
|
N
|
%
|
N
|
%
|
|
|
Demographic characteristics
|
||||||
|
Age, mean (SD)**
|
74.9 (8.6)
|
72.9 (8.0)
|
77.7 (8.7)
|
|||
|
Education##
|
||||||
|
No formal schooling
|
46
|
15.8
|
16
|
9.5
|
30
|
24.4
|
|
Primary
|
98
|
33.7
|
58
|
34.5
|
40
|
32.5
|
|
Secondary
|
90
|
30.9
|
64
|
38.1
|
26
|
21.1
|
|
Tertiary or above
|
53
|
18.2
|
28
|
16.7
|
25
|
20.3
|
|
Unknown
|
4
|
1.4
|
2
|
1.2
|
2
|
1.6
|
|
Marital status#
|
||||||
|
Married
|
222
|
76.3
|
138
|
82.1
|
84
|
68.3
|
|
Single
|
17
|
5.8
|
10
|
6.0
|
7
|
5.7
|
|
Separated, divorced or widower
|
48
|
16.5
|
18
|
10.7
|
30
|
24.4
|
|
Unknown
|
4
|
1.4
|
2
|
1.2
|
2
|
1.6
|
|
Currently working
|
||||||
|
Yes
|
25
|
8.6
|
20
|
11.9
|
5
|
4.1
|
|
No
|
262
|
90.0
|
146
|
86.9
|
116
|
94.3
|
|
Unknown
|
4
|
1.4
|
2
|
1.2
|
2
|
1.6
|
|
Monthly income (HKD$)
|
||||||
|
<20,000
|
238
|
81.8
|
133
|
79.2
|
105
|
85.4
|
|
>20,000
|
49
|
16.8
|
33
|
19.6
|
16
|
13.0
|
|
Unknown
|
4
|
1.4
|
2
|
1.2
|
2
|
1.6
|
|
Clinical characteristics
|
||||||
|
PSA
|
||||||
|
<0.1 ng/ml
|
109
|
37.5
|
70
|
41.7
|
39
|
31.7
|
|
>0.1 and <10 ng/ml
|
121
|
41.6
|
60
|
35.7
|
61
|
49.6
|
|
>10 ng/ml
|
39
|
13.4
|
24
|
14.3
|
15
|
12.2
|
|
Unknown
|
22
|
7.6
|
14
|
8.3
|
8
|
6.5
|
|
AJCC cancer stage
|
||||||
|
I
|
58
|
19.9
|
27
|
16.1
|
31
|
25.2
|
|
II
|
75
|
25.8
|
42
|
25.0
|
33
|
26.8
|
|
III
|
31
|
10.7
|
20
|
11.9
|
11
|
8.9
|
|
IV
|
112
|
38.5
|
70
|
41.7
|
42
|
34.1
|
|
Unknown
|
15
|
5.2
|
9
|
5.4
|
6
|
4.9
|
|
Distant metastasis
|
59
|
20.3
|
37
|
22.0
|
22
|
17.9
|
|
KPS##
|
||||||
|
Mean (SD)**
|
91.4 (12.5)
|
94.1 (8.7)
|
87.6 (15.6)
|
|||
|
<70
|
23
|
7.9
|
5
|
2.98
|
18
|
14.6
|
|
80
|
34
|
11.7
|
16
|
9.52
|
18
|
14.6
|
|
90
|
64
|
22.0
|
39
|
23.21
|
25
|
20.3
|
|
100
|
138
|
47.4
|
90
|
53.57
|
48
|
39.0
|
|
Unknown
|
32
|
11.0
|
18
|
10.71
|
14
|
11.4
|
|
Treatments
|
||||||
|
Watchful waiting/active surveillance
|
24
|
8.12
|
12
|
7.1
|
12
|
9.8
|
|
Androgen deprivation/combined androgen blockade
|
117
|
40.2
|
65
|
38.7
|
52
|
42.3
|
|
Radical prostatectomy#
|
102
|
35.1
|
68
|
40.5
|
34
|
27.6
|
|
Radical curative radiation
|
45
|
15.5
|
26
|
15.5
|
19
|
15.4
|
|
Adjuvant radiation
|
8
|
2.7
|
4
|
2.4
|
4
|
3.3
|
|
Chemotherapy
|
4
|
1.4
|
2
|
1.2
|
2
|
1.6
|
|
HRQOL scores
|
Mean (SD)
|
Mean (SD)
|
Mean (SD)
|
|---|---|---|---|
|
Condition-specific, FACT-P
|
|||
|
PWB**
|
24.6 (3.6)
|
25.7 (2.6)
|
23.2 (4.3)
|
|
SWB**
|
19.6 (5.2)
|
20.6 (4.3)
|
18.3 (6.0)
|
|
EWB
|
21.1 (3.8)
|
21.4 (3.3)
|
20.7 (4.3)
|
|
FWB**
|
19.7 (5.4)
|
20.9 (4.7)
|
18.1 (5.8)
|
|
PCS**
|
35.9 ± (6.5)
|
37.5 (5.6)
|
33.7 (6.9)
|
|
TOI**
|
80.2 ± (13.7)
|
84.0 (11.3)
|
75.0 (15.0)
|
|
FACT-G total score**
|
85.0 ± (13.9)
|
88.5 (11.6)
|
80.3 (15.4)
|
|
FACT-P total score**
|
120.9 ± (19.2)
|
126.0 (16.0)
|
114.0 (21.1)
|
|
Generic, SF-12v2
|
|||
|
PF**
|
67.2 (34.7)
|
78.7 (28.4)
|
51.2 (36.3)
|
|
RP**
|
71.1 (26.9)
|
78.9 (22.8)
|
60.5 (28.4)
|
|
BP**
|
75.1 (27.6)
|
82.6 (22.2)
|
64.7 (30.9)
|
|
GH**
|
59.4 (27.2)
|
67.1 (24.1)
|
48.8 (27.9)
|
|
VT**
|
70.1 (24.6)
|
75.1 (23.3)
|
63.1 (24.7)
|
|
SF**
|
76.7 (26.2)
|
82.9 (22.6)
|
68.2 (28.4)
|
|
RE*
|
84.8 (22.2)
|
87.6 (19.4)
|
80.9 (25.2)
|
|
MH**
|
81.3 (19.3)
|
84.4 (17.3)
|
76.8 (21.0)
|
|
PCS-12**
|
43.4 (13.5)
|
47.8 (10.7)
|
37.3 (14.6)
|
|
MCS-12
|
57.4 (9.9)
|
58.0 (8.9)
|
56.5 (11.2)
|